- Home
- DERM vs VTGN Comparison
DERM vs VTGN Comparison
Compare DERM & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- VTGN
- Stock Information
- Founded
- DERM 2014
- VTGN 1998
- Country
- DERM United States
- VTGN United States
- Employees
- DERM N/A
- VTGN N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- DERM Health Care
- VTGN Health Care
- Exchange
- DERM Nasdaq
- VTGN Nasdaq
- Market Cap
- DERM 95.0M
- VTGN 82.7M
- IPO Year
- DERM 2021
- VTGN N/A
- Fundamental
- Price
- DERM $5.19
- VTGN $2.93
- Analyst Decision
- DERM Strong Buy
- VTGN
- Analyst Count
- DERM 3
- VTGN 0
- Target Price
- DERM $9.50
- VTGN N/A
- AVG Volume (30 Days)
- DERM 55.0K
- VTGN 192.7K
- Earning Date
- DERM 03-20-2025
- VTGN 02-13-2025
- Dividend Yield
- DERM N/A
- VTGN N/A
- EPS Growth
- DERM N/A
- VTGN N/A
- EPS
- DERM N/A
- VTGN N/A
- Revenue
- DERM $57,771,000.00
- VTGN $698,000.00
- Revenue This Year
- DERM N/A
- VTGN N/A
- Revenue Next Year
- DERM $36.49
- VTGN N/A
- P/E Ratio
- DERM N/A
- VTGN N/A
- Revenue Growth
- DERM N/A
- VTGN N/A
- 52 Week Low
- DERM $2.85
- VTGN $2.22
- 52 Week High
- DERM $6.89
- VTGN $5.74
- Technical
- Relative Strength Index (RSI)
- DERM 60.26
- VTGN 53.66
- Support Level
- DERM $4.85
- VTGN $2.72
- Resistance Level
- DERM $5.37
- VTGN $3.10
- Average True Range (ATR)
- DERM 0.40
- VTGN 0.19
- MACD
- DERM 0.02
- VTGN 0.00
- Stochastic Oscillator
- DERM 70.49
- VTGN 66.00
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.